Detailansicht

Wissensnetz

Person

Johann Bauersachs

Arzt

Name	Johann Bauersachs
Ort	Hannover (2010-) (Wirkungsort) Deutschland
Geschlecht	männlich
Akademischer Grad bzw. Titel	Prof. Dr. med.
Beruf	Arzt (charakteristischer Beruf) Internist
Variante	J. Bauersachs
Beziehung	Medizinische Hochschule Hannover (2010-) Klinik für Kardiologie und Angiologie (Hannover) (Direktor) (2010-)
Weitere Angaben	Promotion Freiburg 1993; Habil. Fach Innere Medizin an der Univ. Würzburg 2001; Verbindung zur Universität Heidelberg, Medizinische Fakultät
Quelle	Homepage: http://www.mh-hannover.de/19750.html
Datensatztyp	Person
GND-Nummer	113864272
Datensatz-ID	113864272
Beteiligt an alle anzeigen Heart failure with preserved ejection fraction: diagnosis, risk assessment, and treatment Cysteine-rich with EGF-like domains 2 (CRELD2) is an endoplasmic reticulum stress-inducible angiogenic growth factor promoting ischemic heart repair Heart failure with preserved ejection fraction: diagnosis, risk assessment, and treatment Hypoxia Attenuates Pressure Overload-Induced Heart Failure Hypoxia Attenuates Pressure Overload‐Induced Heart Failure Rationale and design of the DIGIT-HF trial (DIGitoxin to Improve ouTcomes in patients with advanced chronic Heart Failure): a randomized, double-blind, placebo-controlled study Diastolic dysfunction is associated with cardiac decompensation after transjugular intrahepatic portosystemic shunt in patients with liver cirrhosis Eine eigene und besondere Phase der Herzinsuffizienz Simple and safe digitoxin dosing in heart failure based on data from the DIGIT-HF trial Eine nicht alltägliche tumorassoziierte Thrombose Frühe Implementierung der „Fantastic four“ bei Herzinsuffizienz mit reduzierter Ejektionsfraktion : Leitliniengerechte medikamentöse Therapie – Ein praktischer Leitfaden Survey of clinical practice pattern in Germany’s certified chest pain units : Adherence to the European Society of Cardiology guidelines on non-ST-segment elevation acute coronary syndrome Ethnic comparison in takotsubo syndrome: novel insights from the International Takotsubo Registry Fibroblast GATA-4 and GATA-6 promote myocardial adaptation to pressure overload by enhancing cardiac angiogenesis Adults with congenital heart disease : relations between neurohormonal activation, immunity, inflammation and heart failure Artificial Intelligence Identifies an Urgent Need for Peripheral Vascular Intervention by Multiplexing Standard Clinical Parameters Die Bedeutung des Mineralokortikoidrezeptors in zirkulierenden Monozyten bei Patienten mit akutem Myokardinfarkt Kritische Rolle des Glukokortikoidrezeptors in Makrophagen für die Heilung und das Remodeling nach Myokardinfarkt Kriterien der Deutschen Gesellschaft für Kardiologie – Herz- und Kreislaufforschung für „Chest Pain Units“ : Update 2020 Cardiac iron concentration in relation to systemic iron status and disease severity in non-ischaemic heart failure with reduced ejection fraction Diverging trends in age at first myocardial infarction: evidence from two German population-based studies Inflammatory Drivers of Cardiovascular Disease: Molecular Characterization of Senescent Coronary Vascular Smooth Muscle Cells Schwerpunkt COVID-19 Adenosine stress perfusion cardiac magnetic resonance imaging in patients undergoing intracoronary bone marrow cell transfer after ST-elevation myocardial infarction: the BOOST-2 perfusion substudy Anti-androgenic therapy with finasteride in patients with chronic heart failure - a retrospective propensity score based analysis TIP 30 counteracts cardiac hypertrophy and failure by inhibiting translational elongation The transcription factor GATA 4 promotes myocardial regeneration in neonatal mice Bromocriptine treatment in patients with peripartum cardiomyopathy and right ventricular dysfunction Heart Failure Efficacy of prasugrel administration immediately after percutaneous coronary intervention in ST-elevation myocardial infarction The transcription factor GATA 4 promotes myocardial regeneration in neonatal mice Heart Failure Deficiency of MAPK-activated protein kinase 2 (MK2) prevents adverse remodelling and promotes endothelial healing after arterial injury Endothelium-dependent and -independent relaxation and VASP serines 157/239 phosphorylation by cyclic nucleotide-elevating vasodilators in rat aorta Aldosteron und Mineralokortikoid-Rezeptor-Blockade – Aktuelle Aspekte Cardiovascular healing - focus on inflammation : Leopoldina Symposium Wuerzburg June 23 to 24, 2006 Cardiovascular healing - focus on inflammation : Leopoldina symposium, Wuerzburg, June 23 to 24, 2006 Aldosteron-Rezeptorblockade : neue Therapieoption für Hochrisiko-Patienten nach akutem Myokardinfarkt Cardiovascular healing : Leopoldina symposium, Würzburg, June 24 to 26, 2004 ; with 7 tables Das Gefäßendothel in der Pathophysiologie von Hypertonie und Herzinsuffizienz : Stickstoffmonoxid, reaktive Sauerstoffradikale, endothelvermittelte Hyperpolarisation Oxidierte Low Density Lipoproteine hemmen cGMP- und cAMP-vermittelte Vasodilatationen an isolierten Arterien des Menschen und des Kaninchens

Hinweis

Die Betaversion beinhaltet noch nicht alle Funktionen und Informationen des Katalogs des DNB-Portals. Falls Sie Informationen vermissen oder ein Medium bestellen wollen, besuchen Sie bitte die entsprechende Seite im Katalog des DNB-Portals über folgenden Link:

Katalog der Deutschen Nationalbibliothek

Johann Bauersachs

Heart failure with preserved ejection fraction: diagnosis, risk assessment, and treatment

Cysteine-rich with EGF-like domains 2 (CRELD2) is an endoplasmic reticulum stress-inducible angiogenic growth factor promoting ischemic heart repair

Heart failure with preserved ejection fraction: diagnosis, risk assessment, and treatment

Hypoxia Attenuates Pressure Overload-Induced Heart Failure

Hypoxia Attenuates Pressure Overload‐Induced Heart Failure

Rationale and design of the DIGIT-HF trial (DIGitoxin to Improve ouTcomes in patients with advanced chronic Heart Failure): a randomized, double-blind, placebo-controlled study

Diastolic dysfunction is associated with cardiac decompensation after transjugular intrahepatic portosystemic shunt in patients with liver cirrhosis

Eine eigene und besondere Phase der Herzinsuffizienz

Simple and safe digitoxin dosing in heart failure based on data from the DIGIT-HF trial

Eine nicht alltägliche tumorassoziierte Thrombose

Frühe Implementierung der „Fantastic four“ bei Herzinsuffizienz mit reduzierter Ejektionsfraktion : Leitliniengerechte medikamentöse Therapie – Ein praktischer Leitfaden

Survey of clinical practice pattern in Germany’s certified chest pain units : Adherence to the European Society of Cardiology guidelines on non-ST-segment elevation acute coronary syndrome

Ethnic comparison in takotsubo syndrome: novel insights from the International Takotsubo Registry

Fibroblast GATA-4 and GATA-6 promote myocardial adaptation to pressure overload by enhancing cardiac angiogenesis

Adults with congenital heart disease : relations between neurohormonal activation, immunity, inflammation and heart failure

Artificial Intelligence Identifies an Urgent Need for Peripheral Vascular Intervention by Multiplexing Standard Clinical Parameters

Die Bedeutung des Mineralokortikoidrezeptors in zirkulierenden Monozyten bei Patienten mit akutem Myokardinfarkt

Kritische Rolle des Glukokortikoidrezeptors in Makrophagen für die Heilung und das Remodeling nach Myokardinfarkt

Kriterien der Deutschen Gesellschaft für Kardiologie – Herz- und Kreislaufforschung für „Chest Pain Units“ : Update 2020

Cardiac iron concentration in relation to systemic iron status and disease severity in non-ischaemic heart failure with reduced ejection fraction

Diverging trends in age at first myocardial infarction: evidence from two German population-based studies

Inflammatory Drivers of Cardiovascular Disease: Molecular Characterization of Senescent Coronary Vascular Smooth Muscle Cells

Schwerpunkt COVID-19

Adenosine stress perfusion cardiac magnetic resonance imaging in patients undergoing intracoronary bone marrow cell transfer after ST-elevation myocardial infarction: the BOOST-2 perfusion substudy

Anti-androgenic therapy with finasteride in patients with chronic heart failure - a retrospective propensity score based analysis

TIP 30 counteracts cardiac hypertrophy and failure by inhibiting translational elongation

The transcription factor GATA 4 promotes myocardial regeneration in neonatal mice

Bromocriptine treatment in patients with peripartum cardiomyopathy and right ventricular dysfunction

Heart Failure

Efficacy of prasugrel administration immediately after percutaneous coronary intervention in ST-elevation myocardial infarction

The transcription factor GATA 4 promotes myocardial regeneration in neonatal mice

Heart Failure

Deficiency of MAPK-activated protein kinase 2 (MK2) prevents adverse remodelling and promotes endothelial healing after arterial injury

Endothelium-dependent and -independent relaxation and VASP serines 157/239 phosphorylation by cyclic nucleotide-elevating vasodilators in rat aorta

Aldosteron und Mineralokortikoid-Rezeptor-Blockade – Aktuelle Aspekte

Cardiovascular healing - focus on inflammation : Leopoldina Symposium Wuerzburg June 23 to 24, 2006

Cardiovascular healing - focus on inflammation : Leopoldina symposium, Wuerzburg, June 23 to 24, 2006

Aldosteron-Rezeptorblockade : neue Therapieoption für Hochrisiko-Patienten nach akutem Myokardinfarkt

Cardiovascular healing : Leopoldina symposium, Würzburg, June 24 to 26, 2004 ; with 7 tables

Das Gefäßendothel in der Pathophysiologie von Hypertonie und Herzinsuffizienz : Stickstoffmonoxid, reaktive Sauerstoffradikale, endothelvermittelte Hyperpolarisation

Oxidierte Low Density Lipoproteine hemmen cGMP- und cAMP-vermittelte Vasodilatationen an isolierten Arterien des Menschen und des Kaninchens